The economic burden of multimorbidity: Protocol for a systematic review
Multimorbidity, also known as multiple long-term conditions, leads to higher healthcare utilisation, including hospitalisation, readmission, and polypharmacy, as well as a financial burden to families, society, and nations. Despite some progress, the economic burden of multimorbidity remains poorly...
Gespeichert in:
| Veröffentlicht in: | PloS one 2024-05, Vol.19 (5), p.e0301485 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 5 |
| container_start_page | e0301485 |
| container_title | PloS one |
| container_volume | 19 |
| creator | Banstola, Amrit Anokye, Nana Pokhrel, Subhash |
| description | Multimorbidity, also known as multiple long-term conditions, leads to higher healthcare utilisation, including hospitalisation, readmission, and polypharmacy, as well as a financial burden to families, society, and nations. Despite some progress, the economic burden of multimorbidity remains poorly understood. This paper outlines a protocol for a systematic review that aims to identify and synthesise comprehensive evidence on the economic burden of multimorbidity, considering various definitions and measurements of multimorbidity, including their implications for future cost-of-illness analyses. The review will include studies involving people of all ages with multimorbidity without any restriction on location and setting. Cost-of-illness studies or studies that examined economic burden including model-based studies will be included, and economic evaluation studies will be excluded. Databases including Scopus (that includes PubMed/MEDLINE), Web of Science, CINAHL Plus, PsycINFO, NHS EED (including the HTA database), and the Cost-Effectiveness Analysis Registry, will be searched until March 2024. The risk of bias within included studies will be independently assessed by two authors using appropriate checklists. A narrative synthesis of the main characteristics and results, by definitions and measurements of multimorbidity, will be conducted. The total economic burden of multimorbidity will be reported as mean annual costs per patient and disaggregated based on counts of diseases, disease clusters, and weighted indices. The results of this review will provide valuable insights for researchers into the key cost components and areas that require further investigation in order to improve the rigour of future studies on the economic burden of multimorbidity. Additionally, these findings will broaden our understanding of the economic impact of multimorbidity, inform us about the costs of inaction, and guide decision-making regarding resource allocation and cost-effective interventions. The systematic review's results will be submitted to a peer-reviewed journal, presented at conferences, and shared via an online webinar for discussion. |
| doi_str_mv | 10.1371/journal.pone.0301485 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_3069285270</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A792379630</galeid><doaj_id>oai_doaj_org_article_1b795c217d8842a6ae8b057db1f5238a</doaj_id><sourcerecordid>A792379630</sourcerecordid><originalsourceid>FETCH-LOGICAL-c642t-ab7f07e3b63a2b58e8d8d031e88f486d61ff56369509a725eb8403ef6a6ce5b63</originalsourceid><addsrcrecordid>eNqNks1u1DAUhSMEoqXwBggiISFYzOCf2HHYoKqCMlKlIihsLSe5nnHlxIPtFObtcZi0mqAuUBaO7O8c33t9suw5RktMS_zu2g2-V3a5dT0sEUW4EOxBdowrShacIPrw4P8oexLCNUKMCs4fZ0dpqXhRlcfZ-dUGcmhc7zrT5PXgW-hzp_NusNF0ztemNXH3Pv_iXXSNs7l2Pld52IUInYpJ4-HGwK-n2SOtbIBn03qSff_08ers8-Li8nx1dnqxaHhB4kLVpUYl0JpTRWomQLSiRRSDELoQvOVYa8YprxiqVEkY1KJAFDRXvAGWVCfZy73v1rogpxkESRGviGCkRIlY7YnWqWu59aZTfiedMvLvhvNrqXwq3ILEdVmxhuCyFaIgiisQNWJlW2PNCBUqeX2YbhvqDtoG-uiVnZnOT3qzkWt3IzFGnBE81vtmcvDu5wAhys6EBqxVPbhhLDx1SjnhVUJf_YPe395ErVXqwPTapYub0VSelhWhZcXpSC3vodLXQnrnlBht0v5M8HYmSEyE33GthhDk6tvX_2cvf8zZ1wfsBpSNm-DsEI3rwxws9mDjXQge9N2UMZJj4G-nIcfAyynwSfbi8IXuRLcJp38AnFn6IQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3069285270</pqid></control><display><type>article</type><title>The economic burden of multimorbidity: Protocol for a systematic review</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Public Library of Science (PLoS)</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Banstola, Amrit ; Anokye, Nana ; Pokhrel, Subhash</creator><contributor>Prazeres, Filipe</contributor><creatorcontrib>Banstola, Amrit ; Anokye, Nana ; Pokhrel, Subhash ; Prazeres, Filipe</creatorcontrib><description>Multimorbidity, also known as multiple long-term conditions, leads to higher healthcare utilisation, including hospitalisation, readmission, and polypharmacy, as well as a financial burden to families, society, and nations. Despite some progress, the economic burden of multimorbidity remains poorly understood. This paper outlines a protocol for a systematic review that aims to identify and synthesise comprehensive evidence on the economic burden of multimorbidity, considering various definitions and measurements of multimorbidity, including their implications for future cost-of-illness analyses. The review will include studies involving people of all ages with multimorbidity without any restriction on location and setting. Cost-of-illness studies or studies that examined economic burden including model-based studies will be included, and economic evaluation studies will be excluded. Databases including Scopus (that includes PubMed/MEDLINE), Web of Science, CINAHL Plus, PsycINFO, NHS EED (including the HTA database), and the Cost-Effectiveness Analysis Registry, will be searched until March 2024. The risk of bias within included studies will be independently assessed by two authors using appropriate checklists. A narrative synthesis of the main characteristics and results, by definitions and measurements of multimorbidity, will be conducted. The total economic burden of multimorbidity will be reported as mean annual costs per patient and disaggregated based on counts of diseases, disease clusters, and weighted indices. The results of this review will provide valuable insights for researchers into the key cost components and areas that require further investigation in order to improve the rigour of future studies on the economic burden of multimorbidity. Additionally, these findings will broaden our understanding of the economic impact of multimorbidity, inform us about the costs of inaction, and guide decision-making regarding resource allocation and cost-effective interventions. The systematic review's results will be submitted to a peer-reviewed journal, presented at conferences, and shared via an online webinar for discussion.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0301485</identifier><identifier>PMID: 38696497</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Analysis ; Care and treatment ; Check lists ; Chronic illnesses ; Comorbidity ; Complications and side effects ; Cost analysis ; Cost benefit analysis ; Cost of Illness ; Costs ; Decision making ; Disease ; Economic aspects ; Economic impact ; Evaluation ; Health Care Costs ; Health care expenditures ; Health services utilization ; Humans ; Illnesses ; Liaison work ; Life expectancy ; Medical care, Cost of ; Medical research ; Medicine and Health Sciences ; Medicine, Experimental ; Multimorbidity ; Older people ; Polypharmacy ; Research and Analysis Methods ; Resource allocation ; Social Sciences ; Study Protocol ; Systematic review ; Systematic Reviews as Topic</subject><ispartof>PloS one, 2024-05, Vol.19 (5), p.e0301485</ispartof><rights>Copyright: © 2024 Banstola et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</rights><rights>COPYRIGHT 2024 Public Library of Science</rights><rights>2024 Banstola et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2024 Banstola et al 2024 Banstola et al</rights><rights>2024 Banstola et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c642t-ab7f07e3b63a2b58e8d8d031e88f486d61ff56369509a725eb8403ef6a6ce5b63</cites><orcidid>0000-0003-3185-9638</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11065216/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11065216/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,861,882,2096,2915,23847,27905,27906,53772,53774,79349,79350</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38696497$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Prazeres, Filipe</contributor><creatorcontrib>Banstola, Amrit</creatorcontrib><creatorcontrib>Anokye, Nana</creatorcontrib><creatorcontrib>Pokhrel, Subhash</creatorcontrib><title>The economic burden of multimorbidity: Protocol for a systematic review</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Multimorbidity, also known as multiple long-term conditions, leads to higher healthcare utilisation, including hospitalisation, readmission, and polypharmacy, as well as a financial burden to families, society, and nations. Despite some progress, the economic burden of multimorbidity remains poorly understood. This paper outlines a protocol for a systematic review that aims to identify and synthesise comprehensive evidence on the economic burden of multimorbidity, considering various definitions and measurements of multimorbidity, including their implications for future cost-of-illness analyses. The review will include studies involving people of all ages with multimorbidity without any restriction on location and setting. Cost-of-illness studies or studies that examined economic burden including model-based studies will be included, and economic evaluation studies will be excluded. Databases including Scopus (that includes PubMed/MEDLINE), Web of Science, CINAHL Plus, PsycINFO, NHS EED (including the HTA database), and the Cost-Effectiveness Analysis Registry, will be searched until March 2024. The risk of bias within included studies will be independently assessed by two authors using appropriate checklists. A narrative synthesis of the main characteristics and results, by definitions and measurements of multimorbidity, will be conducted. The total economic burden of multimorbidity will be reported as mean annual costs per patient and disaggregated based on counts of diseases, disease clusters, and weighted indices. The results of this review will provide valuable insights for researchers into the key cost components and areas that require further investigation in order to improve the rigour of future studies on the economic burden of multimorbidity. Additionally, these findings will broaden our understanding of the economic impact of multimorbidity, inform us about the costs of inaction, and guide decision-making regarding resource allocation and cost-effective interventions. The systematic review's results will be submitted to a peer-reviewed journal, presented at conferences, and shared via an online webinar for discussion.</description><subject>Analysis</subject><subject>Care and treatment</subject><subject>Check lists</subject><subject>Chronic illnesses</subject><subject>Comorbidity</subject><subject>Complications and side effects</subject><subject>Cost analysis</subject><subject>Cost benefit analysis</subject><subject>Cost of Illness</subject><subject>Costs</subject><subject>Decision making</subject><subject>Disease</subject><subject>Economic aspects</subject><subject>Economic impact</subject><subject>Evaluation</subject><subject>Health Care Costs</subject><subject>Health care expenditures</subject><subject>Health services utilization</subject><subject>Humans</subject><subject>Illnesses</subject><subject>Liaison work</subject><subject>Life expectancy</subject><subject>Medical care, Cost of</subject><subject>Medical research</subject><subject>Medicine and Health Sciences</subject><subject>Medicine, Experimental</subject><subject>Multimorbidity</subject><subject>Older people</subject><subject>Polypharmacy</subject><subject>Research and Analysis Methods</subject><subject>Resource allocation</subject><subject>Social Sciences</subject><subject>Study Protocol</subject><subject>Systematic review</subject><subject>Systematic Reviews as Topic</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>DOA</sourceid><recordid>eNqNks1u1DAUhSMEoqXwBggiISFYzOCf2HHYoKqCMlKlIihsLSe5nnHlxIPtFObtcZi0mqAuUBaO7O8c33t9suw5RktMS_zu2g2-V3a5dT0sEUW4EOxBdowrShacIPrw4P8oexLCNUKMCs4fZ0dpqXhRlcfZ-dUGcmhc7zrT5PXgW-hzp_NusNF0ztemNXH3Pv_iXXSNs7l2Pld52IUInYpJ4-HGwK-n2SOtbIBn03qSff_08ers8-Li8nx1dnqxaHhB4kLVpUYl0JpTRWomQLSiRRSDELoQvOVYa8YprxiqVEkY1KJAFDRXvAGWVCfZy73v1rogpxkESRGviGCkRIlY7YnWqWu59aZTfiedMvLvhvNrqXwq3ILEdVmxhuCyFaIgiisQNWJlW2PNCBUqeX2YbhvqDtoG-uiVnZnOT3qzkWt3IzFGnBE81vtmcvDu5wAhys6EBqxVPbhhLDx1SjnhVUJf_YPe395ErVXqwPTapYub0VSelhWhZcXpSC3vodLXQnrnlBht0v5M8HYmSEyE33GthhDk6tvX_2cvf8zZ1wfsBpSNm-DsEI3rwxws9mDjXQge9N2UMZJj4G-nIcfAyynwSfbi8IXuRLcJp38AnFn6IQ</recordid><startdate>20240502</startdate><enddate>20240502</enddate><creator>Banstola, Amrit</creator><creator>Anokye, Nana</creator><creator>Pokhrel, Subhash</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-3185-9638</orcidid></search><sort><creationdate>20240502</creationdate><title>The economic burden of multimorbidity: Protocol for a systematic review</title><author>Banstola, Amrit ; Anokye, Nana ; Pokhrel, Subhash</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c642t-ab7f07e3b63a2b58e8d8d031e88f486d61ff56369509a725eb8403ef6a6ce5b63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Analysis</topic><topic>Care and treatment</topic><topic>Check lists</topic><topic>Chronic illnesses</topic><topic>Comorbidity</topic><topic>Complications and side effects</topic><topic>Cost analysis</topic><topic>Cost benefit analysis</topic><topic>Cost of Illness</topic><topic>Costs</topic><topic>Decision making</topic><topic>Disease</topic><topic>Economic aspects</topic><topic>Economic impact</topic><topic>Evaluation</topic><topic>Health Care Costs</topic><topic>Health care expenditures</topic><topic>Health services utilization</topic><topic>Humans</topic><topic>Illnesses</topic><topic>Liaison work</topic><topic>Life expectancy</topic><topic>Medical care, Cost of</topic><topic>Medical research</topic><topic>Medicine and Health Sciences</topic><topic>Medicine, Experimental</topic><topic>Multimorbidity</topic><topic>Older people</topic><topic>Polypharmacy</topic><topic>Research and Analysis Methods</topic><topic>Resource allocation</topic><topic>Social Sciences</topic><topic>Study Protocol</topic><topic>Systematic review</topic><topic>Systematic Reviews as Topic</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Banstola, Amrit</creatorcontrib><creatorcontrib>Anokye, Nana</creatorcontrib><creatorcontrib>Pokhrel, Subhash</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Banstola, Amrit</au><au>Anokye, Nana</au><au>Pokhrel, Subhash</au><au>Prazeres, Filipe</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The economic burden of multimorbidity: Protocol for a systematic review</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2024-05-02</date><risdate>2024</risdate><volume>19</volume><issue>5</issue><spage>e0301485</spage><pages>e0301485-</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Multimorbidity, also known as multiple long-term conditions, leads to higher healthcare utilisation, including hospitalisation, readmission, and polypharmacy, as well as a financial burden to families, society, and nations. Despite some progress, the economic burden of multimorbidity remains poorly understood. This paper outlines a protocol for a systematic review that aims to identify and synthesise comprehensive evidence on the economic burden of multimorbidity, considering various definitions and measurements of multimorbidity, including their implications for future cost-of-illness analyses. The review will include studies involving people of all ages with multimorbidity without any restriction on location and setting. Cost-of-illness studies or studies that examined economic burden including model-based studies will be included, and economic evaluation studies will be excluded. Databases including Scopus (that includes PubMed/MEDLINE), Web of Science, CINAHL Plus, PsycINFO, NHS EED (including the HTA database), and the Cost-Effectiveness Analysis Registry, will be searched until March 2024. The risk of bias within included studies will be independently assessed by two authors using appropriate checklists. A narrative synthesis of the main characteristics and results, by definitions and measurements of multimorbidity, will be conducted. The total economic burden of multimorbidity will be reported as mean annual costs per patient and disaggregated based on counts of diseases, disease clusters, and weighted indices. The results of this review will provide valuable insights for researchers into the key cost components and areas that require further investigation in order to improve the rigour of future studies on the economic burden of multimorbidity. Additionally, these findings will broaden our understanding of the economic impact of multimorbidity, inform us about the costs of inaction, and guide decision-making regarding resource allocation and cost-effective interventions. The systematic review's results will be submitted to a peer-reviewed journal, presented at conferences, and shared via an online webinar for discussion.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>38696497</pmid><doi>10.1371/journal.pone.0301485</doi><tpages>e0301485</tpages><orcidid>https://orcid.org/0000-0003-3185-9638</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1932-6203 |
| ispartof | PloS one, 2024-05, Vol.19 (5), p.e0301485 |
| issn | 1932-6203 1932-6203 |
| language | eng |
| recordid | cdi_plos_journals_3069285270 |
| source | MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Public Library of Science (PLoS); PubMed Central; Free Full-Text Journals in Chemistry |
| subjects | Analysis Care and treatment Check lists Chronic illnesses Comorbidity Complications and side effects Cost analysis Cost benefit analysis Cost of Illness Costs Decision making Disease Economic aspects Economic impact Evaluation Health Care Costs Health care expenditures Health services utilization Humans Illnesses Liaison work Life expectancy Medical care, Cost of Medical research Medicine and Health Sciences Medicine, Experimental Multimorbidity Older people Polypharmacy Research and Analysis Methods Resource allocation Social Sciences Study Protocol Systematic review Systematic Reviews as Topic |
| title | The economic burden of multimorbidity: Protocol for a systematic review |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T04%3A40%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20economic%20burden%20of%20multimorbidity:%20Protocol%20for%20a%20systematic%20review&rft.jtitle=PloS%20one&rft.au=Banstola,%20Amrit&rft.date=2024-05-02&rft.volume=19&rft.issue=5&rft.spage=e0301485&rft.pages=e0301485-&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0301485&rft_dat=%3Cgale_plos_%3EA792379630%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3069285270&rft_id=info:pmid/38696497&rft_galeid=A792379630&rft_doaj_id=oai_doaj_org_article_1b795c217d8842a6ae8b057db1f5238a&rfr_iscdi=true |